Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Home
ETF
ONC
ONC
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
ONC News
BeOne Medicines AG Raises 2026 Revenue Guidance Amid Strong Q4 Results
Mar 01 2026
Yahoo Finance
BeiGene to Announce Q4 Earnings on February 26
Feb 25 2026
seekingalpha
Three Growth Stocks to Buy and Hold Long-Term
Feb 21 2026
Fool
HHLR Advisors Fully Exits Baidu Position
Feb 20 2026
Fool
Three Stocks Set to Outperform the Market in 2026
Feb 16 2026
Fool
BeOne Medicines to Report Q4 and Full Year 2025 Financial Results
Feb 11 2026
Newsfilter
Amazon and BeOne Medicines Show Promising Prospects
Feb 02 2026
NASDAQ.COM
February Investment Opportunities: Amazon and Three Stocks to Buy
Feb 02 2026
Fool
FDA Accepts Summit Therapeutics' BLA for Ivonescimab
Jan 29 2026
Benzinga
S&P 500 and Dow Reverse Gains as Nasdaq Narrows Upturn
Jan 08 2026
Yahoo Finance
S&P 500 and Dow Retreat from Highs, Eli Lilly and Google Flash Buy Signals
Jan 08 2026
Yahoo Finance
Jazz Pharmaceuticals Reports Ziihera Trial Shows Significant Survival Benefits
Jan 07 2026
Benzinga
BeOne Reports ZIIHERA Trial Results, Significant Survival Improvement Observed
Jan 06 2026
Businesswire
BeOne Medicines (ONC) Shares Oversold with RSI at 28.4, Potential Buy Signal
Dec 30 2025
NASDAQ.COM
BeOne Medicines to Present at 2026 J.P. Morgan Healthcare Conference
Dec 23 2025
Yahoo Finance
BeOne Medicines Receives FDA Fast Track Designation for BGB-B2033 in Liver Cancer Treatment
Dec 18 2025
Newsfilter
Show More News
